Publications

Paris Wallace (He/Him) is the CEO & Founder of NCL (Hiring). EIR @ Harvard Business School. Investor. DEI Crusader. Cyclist. Ovia Health (Acquired: LH). Good Start Genetics (Acquired: NVTA) Paris is the founder and CEO of the NCL the... View Details

Keywords: Biotech & Life Sciences;#19;#Digital Health;#43;#Healthcare;#56;#Personal Health & Wellness;#64;#Software/App

27 Jan 2003
Research & Ideas

New Cluster Mapping Project Helps Companies Locate Facilities

Too often corporations decide to locate facilities based solely on cost savings. And that's shortsighted, argues Harvard Business School professor Michael Porter. Instead, business leaders should look for locations that gather... View Details

Keywords: by Sean Silverthorne

2004
Chapter

Genzyme's Gaucher Initiative: Global Risk and Responsibility

By: Christopher A. Bartlett and Andrew N. McLean

Keywords: Health Disorders; Corporate Social Responsibility and Impact; Globalization; Risk and Uncertainty; Health Industry; Health Industry

06 Mar 2018
News

A Voice for Diversity and Impact at Scale

scaling local knowledge. Back in the United States, that realization led Hunt to explore other aspects of the health care industry’s value chain, from billing to insurance to product development. “I loved the sense that I was working in... View Details

10 Oct 2000
Research & Ideas

Cross-Sector Collaboration: Lessons from the International Trachoma Initiative

The aim, write the authors, is "to deepen our understanding of the process of cross-sector collaboration in the public health arena and the factors contributing to effective partnering." They begin with brief descriptions of... View Details

Keywords: by Diana Barrett, James Austin & Sheila McCarthy

17 Jul 2017
Op-Ed

Op-Ed: As America Recedes from Global Leadership, Its CEOs are Stepping Up

As America recedes from global leadership under President Donald Trump’s “America First” policies, a new generation of business statesmen is stepping up to take on global issues of monumental importance: global trade, climate change, job creation, and healthy living.... View Details

Keywords: by Bill George

April 2006 (Revised May 2009)
Case

Inverness Medical Innovations - Born Global (A)

Ron Zwanziger has just started his third company, having just sold the last one for $1.3 billion to Johnson & Johnson. As part of the deal with J&J, certain assets were transferred to the new company, Inverness Medical Innovations, which, at the time of its creation,... View Details

Keywords: Globalized Firms and Management; Mergers and Acquisitions; Entrepreneurship; Health Care and Treatment; Corporate Finance; Health Industry; Health Industry; Waltham

22 Sep 2003
Research & Ideas

How Businesses Can Respond to AIDS

Asia: Building Sustainable Partnerships," held September 4 and 5, brought together over seventy participants from business, government, non-governmental organizations, and activist groups to share experiences and offer a strong View Details

Keywords: by Martha Lagace

15 Apr 2021
News

Bringing Light to the Fight

symbol of health care activism, not the internationally recognized icon it is today. Starting a public conversation about women’s health was not easy, certainly, but the foundation believed that education... View Details

03 Aug 2022
News

Hungry for Change

that hunger, Sun & Swell was born in 2016. “We started with the mission of bringing healthier foods to the world,” says Flynn. But that goal quickly expanded as she began to research the grocery and packaged food industry. Packaged food wasn’t only a detriment to the... View Details

Keywords: April White

01 Jun 2007
News

HBS Faculty Member Honored

Between Competitive Advantage and Corporate Social Responsibility,” the coauthors propose a way for firms to contribute to social welfare without sacrificing corporate success. Porter was also honored (with... View Details

Keywords: Colleges, Universities, and Professional Schools; Educational Services

July 2000 (Revised September 2005)
Case

Guidant: Radiation Therapy

Describes a potential new approach to treating cardiac disease--radiation therapy. Guidant, a leading medical device maker, faces a choice about whether to pursue this new and risky technology and, if so with what strategy. View Details

Keywords: Entrepreneurship; Decisions; Innovation Strategy; Health Care and Treatment; Product Design; Corporate Strategy; Medical Specialties; Health Industry; Health Industry

October 2020 (Revised November 2023)
Case

COVID-19 Testing at Everlywell

By: Jeffrey J. Bussgang and Olivia Hull

In March 2020, as COVID-19 spreads rapidly across the U.S., Everlywell founder Julia Cheek considers how to respond as a small start-up specializing in at-home lab testing. After making dramatic budget cuts, she decides to pivot the organization to address the... View Details

January 2025
Supplement

Creating Value by Splitting Aster (B): Can One Minus One Equal Two?

By: V.G. Narayanan and Kairavi Dey

Keywords: Corporate Governance; Corporate Accountability; Leadership; Change Management; Mergers and Acquisitions; Health Industry; Asia; India; Middle East; United Arab Emirates

29 May 2020
Op-Ed

How Leaders Are Fighting Food Insecurity on Three Continents

COVID-19 is creating unprecedented strains on food security worldwide. The United Nations' World Food Programme warns that the pandemic could almost double the number of people facing food crises in low- and middle-income populations to 265 million by the end of 2020.... View Details

Keywords: by Howard Stevenson and Shirley Spence; Agriculture & Agribusiness

October 2024
Case

Allurion: Competing in the Age of GLP-1

By: Satish Tadikonda, Rajiv Lal, David Lane and Sarah Sasso

Shantanu Gaur had built Allurion into a formidable business internationally, providing obesity patients with a less invasive option long before GLP-1 drugs became the latest craze. Selling Allurion's medical device across 60+ countries, he awaited FDA approval to bring... View Details

Keywords: Corporate Entrepreneurship; Health Care and Treatment; Global Strategy; Competitive Strategy; Market Entry and Exit; Health Industry; Health Industry; United States; United Kingdom; France; India; Brazil; Middle East